The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review
PET and PET/CT are widely used for surveillance of patients after cancer treatments. We
conducted a systematic review to assess the diagnostic accuracy and clinical impact of PET …
conducted a systematic review to assess the diagnostic accuracy and clinical impact of PET …
NCCN task force: clinical utility of PET in a variety of tumor types
DA Podoloff, DW Ball, E Ben-Josef, AB Benson… - Journal of the National …, 2009 - jnccn.org
Use of PET is widespread and increasing in the United States, mainly for oncologic
applications. In November 2006, the National Comprehensive Cancer Network (NCCN) …
applications. In November 2006, the National Comprehensive Cancer Network (NCCN) …
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic …
S Morbelli, S Capitanio, F De Carli… - European journal of …, 2016 - Springer
Purpose To identify both clinical and FDG PET/CT-derived factors predicting the occurrence
of relapse, or conversely, the likelihood of false positive findings in surveillance FDG …
of relapse, or conversely, the likelihood of false positive findings in surveillance FDG …
[HTML][HTML] On the added value of baseline FDG-PET in malignant lymphoma
H Quarles van Ufford, O Hoekstra, M de Haas… - Molecular imaging and …, 2010 - Springer
Purpose The added value of baseline positron emission tomography (PET) scans in therapy
evaluation in malignant lymphoma is unclear. In guidelines, baseline PET is recommended …
evaluation in malignant lymphoma is unclear. In guidelines, baseline PET is recommended …
PET‐CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient
KA Dunsky, DJ Wehrmann, MM Osman… - The …, 2013 - Wiley Online Library
Objectives/Hypothesis The role of follow‐up and the detection of recurrent or new primary
disease in cancer management remains to be defined. Specifically, the effectiveness and …
disease in cancer management remains to be defined. Specifically, the effectiveness and …
Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging
MS Hofman, NC Smeeton, SC Rankin… - Journal of Nuclear …, 2009 - Soc Nuclear Med
Many studies demonstrate a high accuracy for PET in staging lymphoma, but few assess
observer variation. This study quantified agreement for staging lymphoma with PET/CT …
observer variation. This study quantified agreement for staging lymphoma with PET/CT …
PET monitoring of therapy response in head and neck squamous cell carcinoma
H Schöder, M Fury, N Lee, D Kraus - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
In the Western world, more than 90% of head and neck cancers are head and neck
squamous cell carcinomas (HNSCCs). The most appropriate treatment approach for …
squamous cell carcinomas (HNSCCs). The most appropriate treatment approach for …
Screening for cancer with PET and PET/CT: potential and limitations
H Schöder, M Gönen - Journal of Nuclear Medicine, 2007 - Soc Nuclear Med
Screening for cancer remains a very emotional and hotly debated issue in contemporary
medical practice. An analysis of published data reveals a multitude of opinions based on a …
medical practice. An analysis of published data reveals a multitude of opinions based on a …
PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study
AM Scott, DH Gunawardana… - Journal of Nuclear …, 2008 - Soc Nuclear Med
The primary aim of this study was to determine the impact of PET in changing initial
management plans in patients with untreated head and neck cancer. Secondary aims were …
management plans in patients with untreated head and neck cancer. Secondary aims were …
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence
AS Ho, GJ Tsao, FW Chen, T Shen, MJ Kaplan… - Cancer, 2013 - Wiley Online Library
BACKGROUND: In head and neck cancer (HNC), 3‐month post‐treatment positron emission
tomography (PET)/computed tomography (CT) reliably identifies persistent/recurrent …
tomography (PET)/computed tomography (CT) reliably identifies persistent/recurrent …
Related searches
- treated lymphoma colorectal cancer
- pet ct neck cancer
- surveillance of patients colorectal cancer
- patients with head neck cancer
- lack of evidence colorectal cancer
- surveillance of patients treated lymphoma
- pet ct asymptomatic recurrence
- tomography surveillance neck cancer
- lack of evidence treated lymphoma
- asymptomatic recurrence neck cancer
- prognostic stratification neck cancer
- impact of pet cancer type
- impact of pet intended management
- fdg pet lymphoma patients
- detrimental effect lymphoma patients
- prognostic stratification patients with head